We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.93B
AUM Growth
+$1.08B
Cap. Flow
+$347M
Cap. Flow %
17.97%
Top 10 Hldgs %
58.78%
Holding
104
New
42
Increased
25
Reduced
17
Closed
19

Top Buys

Rank Stock Value
1
ARKG icon
ARK Genomic Revolution ETF
ARKG
+$80M
2
XLRN
Acceleron Pharma
XLRN
+$31.3M
3
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
+$24.2M
4
CYH icon
Community Health Systems
CYH
+$23.5M
5
MCK icon
McKesson
MCK
+$22.4M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$23.6M
2
ENSG icon
The Ensign Group
ENSG
+$15.4M
3
CTLT
CATALENT, INC.
CTLT
+$13M
4
HSKA
Heska Corp
HSKA
+$11.5M
5
RAD
Rite Aid Corporation
RAD
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 58.91%
2 Miscellaneous 40.99%
3 Consumer Discretionary 0.06%
4 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNCE
101
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-103,829
Closed -$1.31M
LCI
102
CALL
DELISTED
Lannett Company, Inc.
LCI
– –
-15,975
Closed -$354K
OTIC
103
DELISTED
Otonomy, Inc.
OTIC
– –
-253,283
Closed -$1.04M
OXFD
104
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
– –
-307,742
Closed -$5.37M
1 2 3 4
5

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Eversept Partners held 104 positions worth $1.93B, up 126% from $852M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Eversept Partners deployed $347M of net new capital in Q1 2021, opening 42 new positions and adding to 25 existing holdings. Its largest new stake was ARK Genomic Revolution ETF: 806,932 shares worth $71.6M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 98% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was The Ensign Group, an estimated $15.4M trimmed.

  • Eversept Partners's largest Q1 2021 buy was ARK Genomic Revolution ETF: 806,932 shares worth $71.6M.
  • Eversept Partners added most to Community Health Systems in Q1 2021, an estimated $23.5M increase.
  • Eversept Partners's biggest Q1 2021 reduction was The Ensign Group, cutting an estimated $15.4M.
  • Eversept Partners fully exited Sarepta Therapeutics in Q1 2021, selling an estimated $23.6M.
  • Eversept Partners's ten largest holdings make up 59% of its $1.93B portfolio in Q1 2021.
  • Eversept Partners opened 42 new positions and closed 19 in Q1 2021.
  • Eversept Partners's portfolio value rose 126% quarter-over-quarter to $1.93B.

Based on Eversept Partners's 13F filing for Q1 2021, filed 13 May 2021.